Cannabis companies are facing financing problems, because the big banks will not take them on as customers Dama Financial is focused on making transparent banking services readily available to the cannabis industry Dama Financial offers turnkey services to clients looking for safe, sustainable and modern financial/payment options Although more than 30 states have legalized cannabis … Continue reading “Dama Financial Provides Access to Transparent Banking Services for Cannabis Industry”
Provides access through bank partners to secure online, safe and convenient banking services for businesses in the cash-intensive cannabis industry Founded by banking and payments industry veterans experienced in building and scaling businesses Partnered with numerous financial institutions to help cash-intensive businesses reduce financial and safety risk, and run their businesses more efficiently Deposits held … Continue reading “Dama Financial is “One to Watch””
Dama Financial today announced finalization of a strategic partnership with Helix TCS (OTCQB: HLIX) to facilitate secure and compliant financial transactions on Helix’s BiotrackTHC® platform, the commercial seed-to-sale software market leader for the legal cannabis industry. According to the update, Helix TCS will offer an additional payment method and access to a banking solution to … Continue reading “NetworkNewsBreaks – Dama Financial and Helix TCS (HLIX) Partner to Bring Legal Cannabis Industry Financial Solutions Through Market-Leading BiotrackTHC® Software”
The advent of the Internet, and increasingly smart computerized technology, has made the world an interconnected place, granting powerful informational tools to help people meet daily challenges. However, those same tools can also be used abusively by bad players, including domestic violence and other offenders acting as cyberstalkers with malicious intent. A report by social … Continue reading “SuperCom Ltd. (NASDAQ: SPCB) Delivers Solutions for Responding to Stalking Threats on Global Basis”
Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced its 2023 operational highlights for its lead candidate, along with future goals. Clene’s lead candidate, CNM-Au8(R), … Continue reading “Clene Inc. (NASDAQ: CLNN) Announces Operational Highlights for Lead Therapeutic Candidate for ALS and MS”
FingerMotion (NASDAQ: FNGR), on Oct. 19, 2023, announced that it filed a federal lawsuit in the United States District Court for the Southern District of New York, FingerMotion, Inc., v. Capybara Research et. al. The case was against defendant Capybara Research, alleging claims for securities fraud, tortious interference with prospective business expectancy and defamation in … Continue reading “NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Issues Capybara Research Litigation Update”
As the electric boat sector is projected to double in value in the next few years, companies operating in the industry are positioning themselves to meet — and even exceed — the expectations this growth could create. For example, Vision Marine Technologies (NASDAQ: VMAR), a global leader and innovator in the performance electric recreational boating … Continue reading “Vision Marine Technologies Inc. (NASDAQ: VMAR) Unveils New E-Boat Model, Names New CFO in Preparation for Industry Growth”
Sigyn Therapeutics (OTCQB: SIGY, SIGYD), a development-stage medical technology company, has released its year-end 2023 financials and additionally disclosed the completion of a 1-for-40 reverse split of its common stock was implemented on January 31, 2024. As a result of this split, Sigyn’s common stock will trade under the ticker symbol “SIGYD” for 20 business … Continue reading “Sigyn Therapeutics Inc. (SIGYD) Completes Reverse Stock Split, Releases Year-End Financial Report for 2023”
James A. Joyce, the Chairman and CEO of development-stage medical technology company Sigyn Therapeutics (OTCQB: SIGYD, SIGY), recently discussed the company’s opportunities, challenges, and decision-making processes in a letter to shareholders (https://nnw.fm/fzlAw). The company is currently focused on the development of four therapeutic candidates to address clearly defined limitations in global health: Sigyn Therapeutics designed … Continue reading “Sigyn Therapeutics Inc. (SIGYD) CEO Discusses Opportunities to Treat Cancer and Drug-Resistant Pathogens in Letter to Shareholders”
From New Orleans (https://nnw.fm/BDDYP) to Michigan (https://nnw.fm/ojdbk), eastward to Massachusetts (https://nnw.fm/70qAh), and across the Atlantic to Europe (https://nnw.fm/UaAam), concerns about confronting rats in the world’s cities continue to occupy news reports. But rats cause even more damage in agriculture. Rodent pest control enterprise SenesTech (NASDAQ: SNES) is based in Arizona has begun to establish a … Continue reading “SenesTech Inc. (NASDAQ: SNES) Continues to Increase Rat Birth Control Product Distribution Through Agreement with Poppe Enterprises”
